NEUBASE THERAPEUTICS INC - COM (NBSE)

CUSIP: 64132K102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
5,869,250
Share change
+3,163,380
Total reported value
$51,532,262
Price per share
$8.78
Number of holders
47
Value change
+$28,574,786
Number of buys
40
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 64132K102?
CUSIP 64132K102 identifies NBSE - NEUBASE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUBASE THERAPEUTICS INC - COM (NBSE) as of Q2 2020

As of 30 Jun 2020, NEUBASE THERAPEUTICS INC - COM (NBSE) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,869,250 shares. The largest 10 holders included GREENLIGHT CAPITAL INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, NORTHERN TRUST CORP, Sio Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, SPHERA FUNDS MANAGEMENT LTD., and VANGUARD GROUP INC. This page lists 47 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.